György Várady

High-Affinity Interaction of Tyrosine Kinase Inhibitors with the ABCG2 Multidrug Transporter

Csilla Özvegy‐Laczka, Tamás Hegedűs, György Várady et al. · Molecular Pharmacology · 2004 · 340 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Multidrug Transporter ABCG2 Prevents Tumor Cell Death Induced by the Epidermal Growth Factor Receptor Inhibitor Iressa (ZD1839, Gefitinib)

N. Barry Elkind, Zsófia Szentpétery, Ágota Apáti et al. · Cancer Research · 2005 · 225 citations

Medicine, Oncology, Pharmacology +17

Function-dependent Conformational Changes of the ABCG2 Multidrug Transporter Modify Its Interaction with a Monoclonal Antibody on the Cell Surface

Csilla Özvegy‐Laczka, György Várady, Gabriella Köblös et al. · Journal of Biological Chemistry · 2004 · 92 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells

Ágota Apáti, Tamás I. Orbán, Nóra Varga et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 2008 · 88 citations

Life Sciences, Cell Biology, Pharmacology +12

Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: Implications for the emergence and reversal of cancer drug resistance

Csilla Hegedüs, Krisztina Truta-Feles, Géza Antalffy et al. · Biochemical Pharmacology · 2012 · 74 citations

Medicine, Oncology, Pharmacology +16